| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |